Search

Your search keyword '"Guillaume Butler-Laporte"' showing total 76 results

Search Constraints

Start Over You searched for: Author "Guillaume Butler-Laporte" Remove constraint Author: "Guillaume Butler-Laporte"
76 results on '"Guillaume Butler-Laporte"'

Search Results

1. The performance of AlphaMissense to identify genes influencing disease

2. HLA allele-calling using multi-ancestry whole-exome sequencing from the UK Biobank identifies 129 novel associations in 11 autoimmune diseases

3. Circulating proteins to predict COVID-19 severity

4. Dehydration is associated with production of organic osmolytes and predicts physical long-term symptoms after COVID-19: a multicenter cohort study

5. Staphylococcus aureus bacteremia mortality across country income groups: A secondary analysis of a systematic review

6. Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative.

7. Causal associations between body fat accumulation and COVID-19 severity: A Mendelian randomization study

8. Low-dose trimethoprim-sulfamethoxazole for the treatment of Pneumocystis jirovecii pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trial

9. Remdesivir and systemic corticosteroids for the treatment of COVID-19: A Bayesian re-analysis

10. Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study.

11. Screening swabs surpass traditional risk factors as predictors of MRSA bacteremia

12. Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial

13. A recurrent hydatid cyst of the thigh diagnosed 13 years after initial presentation

14. Proteome-wide Mendelian randomization implicates nephronectin as an actionable mediator of the effect of obesity on COVID-19 severity

15. Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases

16. COL6A3-derived endotrophin mediates the effect of obesity on coronary artery disease: an integrative proteogenomics analysis

17. Non-invasive diagnosis of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis

18. Increasing serum iron levels and their role in the risk of infectious diseases: a Mendelian randomization approach

19. Vitamin D and the preclinical Alzheimer cognitive composite cognition (PACC) score: a two-sample mendelian randomization study

21. Low-dose trimethoprim-sulfamethoxazole for the treatment of

22. A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity

23. The relative contributions of obesity, vitamin D, leptin, and adiponectin to multiple sclerosis risk: A Mendelian randomization mediation analysis

24. Effect of tocilizumab, sarilumab, and baricitinib on mortality among patients hospitalized for COVID-19 treated with corticosteroids: a systematic review and meta-analysis

25. UK Nutrition Research Partnership 'Hot Topic' workshop: Vitamin D-A multi-disciplinary approach to (1) elucidate its role in human health and (2) develop strategies to improve vitamin D status in the UK population

26. What Is the Optimal Follow-up Length for Mortality in Staphylococcus aureus Bacteremia? Observations From a Systematic Review of Attributable Mortality

27. Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis

28. Adjunctive Daptomycin in the Treatment of Methicillin-susceptible Staphylococcus aureus Bacteremia: A Randomized, Controlled Trial

29. Remdesivir for the Treatment of COVID-19: An Updated Systematic Review and Meta-Analysis

30. Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis

31. What Is the Optimal Follow-up Length for Mortality in

32. On the Treatment of Pneumocystis jirovecii Pneumonia: Current Practice Based on Outdated Evidence

33. Circulating proteins to predict adverse COVID-19 outcomes

34. Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity

35. On the Treatment of

36. Association of rare predicted loss-of-function variants of influenza-related type I IFN genes with critical COVID-19 pneumonia. Reply

37. Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19

38. Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study

39. Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals

41. SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues

42. MRSA colonization status as a predictor of clinical infection: A systematic review and meta-analysis

43. Comparative effectiveness of amphotericin B, azoles and echinocandins in the treatment of candidemia and invasive candidiasis: A systematic review and network meta-analysis

44. Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality

45. Alternative splicing of OAS1 alters the risk for severe COVID-19

46. Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2: A Systematic Review and Meta-analysis

47. Failure to replicate the association of rare loss-of-function variants in type I IFN immunity genes with severe COVID-19

48. The effect of angiotensin-converting enzyme levels on Covid-19 susceptibility and severity: a Mendelian randomization study

49. Targeted caspofungin prophylaxis for invasive aspergillosis in high-risk liver transplant recipients, a single-center experience

50. A catalog of associations between rare coding variants and COVID-19 outcomes

Catalog

Books, media, physical & digital resources